Single‐cell RNA‐seq reveals clonal diversity and prognostic genes of relapsed multiple myeloma

BACKGROUND: Multiple myeloma (MM) is a clinically and biologically heterogeneous plasma‐cell malignancy. Despite extensive research, disease heterogeneity and relapse remain a big challenge in MM therapeutics. We tried to dissect this disease and identify novel biomarkers for patient stratification...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Haiyan, Li, Zifeng, Lu, Jing, Qiang, Wanting, Jiang, Sihan, Xu, Yaochen, Fu, Weijun, Zhai, Xiaowen, Zhou, Lin, Qian, Maoxiang, Du, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926895/
https://www.ncbi.nlm.nih.gov/pubmed/35297204
http://dx.doi.org/10.1002/ctm2.757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926895/
https://www.ncbi.nlm.nih.gov/pubmed/35297204
http://dx.doi.org/10.1002/ctm2.757

Ejemplares similares